Загрузка...
Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome
Tyrosine kinase inhibitors (TKIs) have been in use as cancer therapeutics for nearly a decade, and their utility in targeting specific malignancies with defined genetic lesions has proven to be remarkably effective. Recent efforts to characterize the spectrum of genetic lesions found in non-small ce...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press Inc.
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069649/ https://ncbi.nlm.nih.gov/pubmed/21461169 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|